- Home
- SHBI vs QURE Comparison
SHBI vs QURE Comparison
Compare SHBI & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SHBI | QURE |
|---|---|---|
| Founded | 1876 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | 248 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 601.1M | 663.4M |
| IPO Year | 1997 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SHBI | QURE |
|---|---|---|
| Price | $17.49 | $14.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $19.17 | ★ $45.42 |
| AVG Volume (30 Days) | 175.6K | ★ 4.4M |
| Earning Date | 04-28-2026 | 03-02-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | ★ 34.85 | 29.67 |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $20,853,000.00 | $13,107,000.00 |
| Revenue This Year | $9.16 | $126.14 |
| Revenue Next Year | $6.71 | $395.00 |
| P/E Ratio | $9.80 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.47 | $7.76 |
| 52 Week High | $20.68 | $71.50 |
Technical Indicators
Market Signals| Indicator | SHBI | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 32.28 | 41.63 |
| Support Level | $17.14 | $13.29 |
| Resistance Level | $17.67 | $16.62 |
| Average True Range (ATR) | 0.52 | 1.69 |
| MACD | -0.10 | 0.24 |
| Stochastic Oscillator | 9.39 | 57.86 |
Price Performance
Historical ComparisonAbout SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.